Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer
Clinical trial NCT05841381 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05841381
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-06
- Primary completion
- 2028-05-06
- Enrollment
- 876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.